PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc.

PMCB
PharmaCyte Biotech, Inc.US flagNASDAQ Capital Market
0.61
USD
+0.00
- -
4.15MMarket Cap

PharmaCyte Biotech, Inc. (PMCB) Stock Split History

Learn about PharmaCyte Biotech, Inc.'s most recent 1-for-1550 basis stock split on July 12, 2021. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about PharmaCyte Biotech, Inc.'s most recent stock split

Split Date: 2021-07-12
Split Ratio: 1:1550
Price Before Split: $0.01
Price After Split: $0.00

Developer API

Get PMCB split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/PMCB

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 1550.00 times fewer shares (a 1:1550 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of PharmaCyte Biotech, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2021-07-121:1550Yes$0.01$0.00
2003-12-083:1NoN/AN/A

About PharmaCyte Biotech, Inc.

Company overview and industry information

PharmaCyte Biotech, Inc. (PMCB) operates in the Biotechnology industry. The recent 1-for-1550 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to PharmaCyte Biotech, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.